Selected research
Industry Research
Knee Osteoarthritis Treatment Industry Research Report 2026
Market perspective
The global Knee Osteoarthritis Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Knee Osteoarthritis Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Knee Osteoarthritis Treatment market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Knee Osteoarthritis Treatment market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Knee Osteoarthritis Treatment include Anika Therapeutics, AVM Biotechnology, Bioventus, Flexion Therapeutics, Horizon Therapeutics, OrthoTrophix, Bayer, GlaxoSmithKline and Pfizer, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Knee Osteoarthritis Treatment market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Knee Osteoarthritis Treatment.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Knee Osteoarthritis Treatment Market by Company
Anika Therapeutics
AVM Biotechnology
Bioventus
Flexion Therapeutics
Horizon Therapeutics
OrthoTrophix
Bayer
GlaxoSmithKline
Pfizer
Eli Lilly
Johnson and Johnson
Sanofi
Abbott
Knee Osteoarthritis Treatment Segment by Type
Non-surgical Treatment
Surgical Treatment
Knee Osteoarthritis Treatment Segment by Application
Ambulatory Surgical Centers
Hospitals
Specialty Clinics
Others
Knee Osteoarthritis Treatment Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Knee Osteoarthritis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Knee Osteoarthritis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Knee Osteoarthritis Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Knee Osteoarthritis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Non-surgical Treatment
- Surgical Treatment
Applications
- Ambulatory Surgical Centers
- Hospitals
- Specialty Clinics
- Others
Companies covered
- Anika Therapeutics
- AVM Biotechnology
- Bioventus
- Flexion Therapeutics
- Horizon Therapeutics
- OrthoTrophix
- Bayer
- GlaxoSmithKline
- Pfizer
- Eli Lilly
- Johnson and Johnson
- Sanofi
- Abbott
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Knee Osteoarthritis Treatment by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Non-surgical Treatment
- 2.2.3 Surgical Treatment
- 2.3 Knee Osteoarthritis Treatment by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Ambulatory Surgical Centers
- 2.3.3 Hospitals
- 2.3.4 Specialty Clinics
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Knee Osteoarthritis Treatment Breakdown Data by Type
- 3.1 Global Knee Osteoarthritis Treatment Historic Market Size by Type (2021-2026)
- 3.2 Global Knee Osteoarthritis Treatment Forecasted Market Size by Type (2027-2032)
4 Knee Osteoarthritis Treatment Breakdown Data by Application
- 4.1 Global Knee Osteoarthritis Treatment Historic Market Size by Application (2021-2026)
- 4.2 Global Knee Osteoarthritis Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Knee Osteoarthritis Treatment Market Perspective (2021-2032)
- 5.2 Global Knee Osteoarthritis Treatment Growth Trends by Region
- 5.2.1 Global Knee Osteoarthritis Treatment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Knee Osteoarthritis Treatment Historic Market Size by Region (2021-2026)
- 5.2.3 Knee Osteoarthritis Treatment Forecasted Market Size by Region (2027-2032)
- 5.3 Knee Osteoarthritis Treatment Market Dynamics
- 5.3.1 Knee Osteoarthritis Treatment Industry Trends
- 5.3.2 Knee Osteoarthritis Treatment Market Drivers
- 5.3.3 Knee Osteoarthritis Treatment Market Challenges
- 5.3.4 Knee Osteoarthritis Treatment Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Knee Osteoarthritis Treatment Players by Revenue
- 6.1.1 Global Top Knee Osteoarthritis Treatment Players by Revenue (2021-2026)
- 6.1.2 Global Knee Osteoarthritis Treatment Revenue Market Share by Players (2021-2026)
- 6.2 Global Knee Osteoarthritis Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Knee Osteoarthritis Treatment Head Office and Area Served
- 6.4 Global Knee Osteoarthritis Treatment Players, Product Type & Application
- 6.5 Global Knee Osteoarthritis Treatment Manufacturers Established Date
- 6.6 Global Knee Osteoarthritis Treatment Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Knee Osteoarthritis Treatment Market Size (2021-2032)
- 7.2 North America Knee Osteoarthritis Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Knee Osteoarthritis Treatment Market Size by Country (2021-2026)
- 7.4 North America Knee Osteoarthritis Treatment Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Knee Osteoarthritis Treatment Market Size (2021-2032)
- 8.2 Europe Knee Osteoarthritis Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Knee Osteoarthritis Treatment Market Size by Country (2021-2026)
- 8.4 Europe Knee Osteoarthritis Treatment Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Knee Osteoarthritis Treatment Market Size (2021-2032)
- 9.2 Asia-Pacific Knee Osteoarthritis Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Knee Osteoarthritis Treatment Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Knee Osteoarthritis Treatment Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Knee Osteoarthritis Treatment Market Size (2021-2032)
- 10.2 South America Knee Osteoarthritis Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Knee Osteoarthritis Treatment Market Size by Country (2021-2026)
- 10.4 South America Knee Osteoarthritis Treatment Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Knee Osteoarthritis Treatment Market Size (2021-2032)
- 11.2 Middle East & Africa Knee Osteoarthritis Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Knee Osteoarthritis Treatment Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Knee Osteoarthritis Treatment Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Anika Therapeutics
- 12.1.1 Anika Therapeutics Company Information
- 12.1.2 Anika Therapeutics Business Overview
- 12.1.3 Anika Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2021-2026)
- 12.1.4 Anika Therapeutics Knee Osteoarthritis Treatment Product Portfolio
- 12.1.5 Anika Therapeutics Recent Developments
- 12.2 AVM Biotechnology
- 12.2.1 AVM Biotechnology Company Information
- 12.2.2 AVM Biotechnology Business Overview
- 12.2.3 AVM Biotechnology Revenue in Knee Osteoarthritis Treatment Business (2021-2026)
- 12.2.4 AVM Biotechnology Knee Osteoarthritis Treatment Product Portfolio
- 12.2.5 AVM Biotechnology Recent Developments
- 12.3 Bioventus
- 12.3.1 Bioventus Company Information
- 12.3.2 Bioventus Business Overview
- 12.3.3 Bioventus Revenue in Knee Osteoarthritis Treatment Business (2021-2026)
- 12.3.4 Bioventus Knee Osteoarthritis Treatment Product Portfolio
- 12.3.5 Bioventus Recent Developments
- 12.4 Flexion Therapeutics
- 12.4.1 Flexion Therapeutics Company Information
- 12.4.2 Flexion Therapeutics Business Overview
- 12.4.3 Flexion Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2021-2026)
- 12.4.4 Flexion Therapeutics Knee Osteoarthritis Treatment Product Portfolio
- 12.4.5 Flexion Therapeutics Recent Developments
- 12.5 Horizon Therapeutics
- 12.5.1 Horizon Therapeutics Company Information
- 12.5.2 Horizon Therapeutics Business Overview
- 12.5.3 Horizon Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2021-2026)
- 12.5.4 Horizon Therapeutics Knee Osteoarthritis Treatment Product Portfolio
- 12.5.5 Horizon Therapeutics Recent Developments
- 12.6 OrthoTrophix
- 12.6.1 OrthoTrophix Company Information
- 12.6.2 OrthoTrophix Business Overview
- 12.6.3 OrthoTrophix Revenue in Knee Osteoarthritis Treatment Business (2021-2026)
- 12.6.4 OrthoTrophix Knee Osteoarthritis Treatment Product Portfolio
- 12.6.5 OrthoTrophix Recent Developments
- 12.7 Bayer
- 12.7.1 Bayer Company Information
- 12.7.2 Bayer Business Overview
- 12.7.3 Bayer Revenue in Knee Osteoarthritis Treatment Business (2021-2026)
- 12.7.4 Bayer Knee Osteoarthritis Treatment Product Portfolio
- 12.7.5 Bayer Recent Developments
- 12.8 GlaxoSmithKline
- 12.8.1 GlaxoSmithKline Company Information
- 12.8.2 GlaxoSmithKline Business Overview
- 12.8.3 GlaxoSmithKline Revenue in Knee Osteoarthritis Treatment Business (2021-2026)
- 12.8.4 GlaxoSmithKline Knee Osteoarthritis Treatment Product Portfolio
- 12.8.5 GlaxoSmithKline Recent Developments
- 12.9 Pfizer
- 12.9.1 Pfizer Company Information
- 12.9.2 Pfizer Business Overview
- 12.9.3 Pfizer Revenue in Knee Osteoarthritis Treatment Business (2021-2026)
- 12.9.4 Pfizer Knee Osteoarthritis Treatment Product Portfolio
- 12.9.5 Pfizer Recent Developments
- 12.10 Eli Lilly
- 12.10.1 Eli Lilly Company Information
- 12.10.2 Eli Lilly Business Overview
- 12.10.3 Eli Lilly Revenue in Knee Osteoarthritis Treatment Business (2021-2026)
- 12.10.4 Eli Lilly Knee Osteoarthritis Treatment Product Portfolio
- 12.10.5 Eli Lilly Recent Developments
- 12.11 Johnson and Johnson
- 12.11.1 Johnson and Johnson Company Information
- 12.11.2 Johnson and Johnson Business Overview
- 12.11.3 Johnson and Johnson Revenue in Knee Osteoarthritis Treatment Business (2021-2026)
- 12.11.4 Johnson and Johnson Knee Osteoarthritis Treatment Product Portfolio
- 12.11.5 Johnson and Johnson Recent Developments
- 12.12 Sanofi
- 12.12.1 Sanofi Company Information
- 12.12.2 Sanofi Business Overview
- 12.12.3 Sanofi Revenue in Knee Osteoarthritis Treatment Business (2021-2026)
- 12.12.4 Sanofi Knee Osteoarthritis Treatment Product Portfolio
- 12.12.5 Sanofi Recent Developments
- 12.13 Abbott
- 12.13.1 Abbott Company Information
- 12.13.2 Abbott Business Overview
- 12.13.3 Abbott Revenue in Knee Osteoarthritis Treatment Business (2021-2026)
- 12.13.4 Abbott Knee Osteoarthritis Treatment Product Portfolio
- 12.13.5 Abbott Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst